Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen said today that it has acquired a minority stake in Alacris Theranostics, a startup using whole-genome sequence analysis to develop individualized cancer therapies.

Qiagen has also acquired a minority stake in EyeSense, a developer of ophthalmic diagnostic systems for glucose monitoring of diabetes patients, EyeSense said in a separate announcement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.